Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial

Kowdley KV, et al. Lancet Gastroenterol Hepatol. 2023;8(12):1118-28

VIEW PUBLICATION

Please note: the "View Publication" button directs you to an external website.